Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2008 Filed Feb 12, 2008 23:53 UTC |
Landgraf John CSenior Vice President
|
SaleCommon shares without par value | 3,300 | $56.89 | $187,737.00 |
DisclosureSEC source: 0001104659-08-009509 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,407 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:53 UTC |
Landgraf John CSenior Vice President
|
SaleCommon shares without par value | 13,500 | $56.90 | $768,150.00 |
DisclosureSEC source: 0001104659-08-009509 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,707 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:53 UTC |
Landgraf John CSenior Vice President
|
SaleCommon shares without par value | 1,079 | $56.74 | $61,222.46 |
DisclosureSEC source: 0001104659-08-009509 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,207 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:53 UTC |
Landgraf John CSenior Vice President
|
SaleCommon shares without par value | 800 | $56.91 | $45,528.00 |
DisclosureSEC source: 0001104659-08-009509 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,286 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:53 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,879 | $53.19 | $99,944.01 |
DisclosureSEC source: 0001104659-08-009509 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,842 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,842 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,902 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,902 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 600 | $56.79 | $34,075.20 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,781 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 5,444 | $56.80 | $309,230.09 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,381 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 700 | $56.79 | $39,753.70 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,825 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 4,842 | $52.66 | $254,979.72 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,902 | $52.55 | $99,950.10 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:56 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,156 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001104659-08-009511 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 11,156 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:56 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 10,556 | $56.76 | $599,158.56 |
DisclosureSEC source: 0001104659-08-009511 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,143 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:56 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 600 | $56.77 | $34,062.00 |
DisclosureSEC source: 0001104659-08-009511 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,699 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:56 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 11,156 | $50.95 | $568,398.20 |
DisclosureSEC source: 0001104659-08-009511 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2008 Filed Feb 8, 2008 01:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value · Derivative | 2,012 | $0.00 Strike: $54.62 | $0.00 |
DisclosureSEC source: 0001104659-08-008184 · a4.xml · derivative · entry 7 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,012 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 05, 2008 Filed Feb 8, 2008 01:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 1,936 | $58.05 | $112,384.80 |
DisclosureSEC source: 0001104659-08-008184 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,411 Read SEC document |
| February 05, 2008 Filed Feb 8, 2008 01:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,012 | $54.62 | $109,895.44 |
DisclosureSEC source: 0001104659-08-008184 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2008 Filed Feb 6, 2009 22:01 UTC |
Szela Mary TSenior Vice President
|
GrantOption (right to buy) · Derivative | 2,996 | $0.00 Strike: $56.98 | $0.00 |
DisclosureSEC source: 0001104659-09-007338 · a4.xml · derivative · entry 5 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,996 Underlying: Common Shares · 2,996 shares Expires 2011-02-08 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:09 UTC |
FULLER H LAURANCEDirector
|
GrantStock equivalent units · Derivative | 480 | $56.15 Strike: $0.00 | $26,952.00 |
DisclosureSEC source: 0001104659-08-000231 · a4.xml · derivative · entry 2 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,776 Underlying: common shares · 480 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:11 UTC |
SCOTT SAMUEL C IIIDirector
|
GrantStock equivalent units · Derivative | 454 | $56.15 Strike: $0.00 | $25,492.10 |
DisclosureSEC source: 0001104659-08-000233 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: common shares · 454 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:12 UTC |
DALEY WILLIAM MDirector
|
GrantStock Equivalent Units · Derivative | 427 | $56.15 Strike: $0.00 | $23,976.05 |
DisclosureSEC source: 0001104659-08-000234 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,713 Underlying: Common shares · 427 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:12 UTC |
TILTON GLENN FDirector
|
GrantStock equivalent units · Derivative | 454 | $56.15 Strike: $0.00 | $25,492.10 |
DisclosureSEC source: 0001104659-08-000235 · a4.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common shares · 454 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:13 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock Equivalent Units · Derivative | 507 | $56.15 Strike: $0.00 | $28,468.05 |
DisclosureSEC source: 0001104659-08-000236 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,679 Underlying: Common shares · 507 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:14 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 267 | $56.15 Strike: $0.00 | $14,992.05 |
DisclosureSEC source: 0001104659-08-000237 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,680 Underlying: Common shares · 267 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 29, 2007 Filed Jan 2, 2008 23:10 UTC |
Hance Robert BSenior Vice President
|
Tax withholdingCommon shares without par value | 1,260 | $57.23 | $72,109.80 |
DisclosureSEC source: 0001104659-08-000232 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,781 Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,286 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,286 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,691 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 6,691 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
SaleCommon shares without par value | 8,977 | $57.58 | $516,850.78 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,711 Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,286 | $43.73 | $99,966.78 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 6,691 | $52.25 | $349,624.15 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2007 Filed Feb 8, 2008 20:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-008542 · a4.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,037,800 Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC |
Patton Donald V JRSenior Vice President
|
GrantOption (right to buy) · Derivative | 6,366 | $0.00 Strike: $58.26 | $0.00 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6.366 Underlying: common shares · 6.366 shares Expires 2009-02-11 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC |
Patton Donald V JRSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,552 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,683 Underlying: common shares · 7,552 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC |
Patton Donald V JRSenior Vice President
|
Tax withholdingCommon shares without par value | 6,366 | $58.26 | $370,883.16 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,068 Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC |
Patton Donald V JRSenior Vice President
|
Exercise / conversionCommon shares without par value | 7,552 | $42.50 | $320,943.39 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2007 Filed Feb 8, 2008 20:52 UTC |
SMITHBURG WILLIAM DDirector
|
GiftCommon shares without par value | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-008551 · a4.xml · nonDerivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,391 Read SEC document |
| December 11, 2007 Filed Dec 12, 2007 23:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 25,602 | $0.00 Strike: $58.90 | $0.00 |
DisclosureSEC source: 0001104659-07-088510 · a4.xml · derivative · entry 11 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,602 Underlying: common shares · 25,602 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 11, 2007 Filed Dec 12, 2007 23:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 10,318 | $0.00 Strike: $58.90 | $0.00 |
DisclosureSEC source: 0001104659-07-088510 · a4.xml · derivative · entry 10 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,318 Underlying: common shares · 10,318 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 11, 2007 Filed Dec 12, 2007 23:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 29,290 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-07-088510 · a4.xml · derivative · entry 9 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 29,290 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 11, 2007 Filed Dec 12, 2007 23:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,767 | $0.00 Strike: $46.92 | $0.00 |
DisclosureSEC source: 0001104659-07-088510 · a4.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 11,767 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 11, 2007 Filed Dec 12, 2007 23:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 35,920 | $58.90 | $2,115,688.00 |
DisclosureSEC source: 0001104659-07-088510 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,335 Read SEC document |
| December 11, 2007 Filed Dec 12, 2007 23:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 29,290 | $46.65 | $1,366,378.50 |
DisclosureSEC source: 0001104659-07-088510 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2007 Filed Dec 12, 2007 23:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 11,767 | $46.92 | $552,102.93 |
DisclosureSEC source: 0001104659-07-088510 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 1,719 | $0.00 Strike: $58.15 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,719 Underlying: Common shares · 1,719 shares Expires 2011-02-08 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 1,731 | $0.00 Strike: $58.15 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,731 Underlying: Common shares · 1,731 shares Expires 2014-02-19 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,200 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,228 Underlying: Common shares · 2,200 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,454 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,672 Underlying: Common shares · 2,454 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Tax withholdingCommon shares without par value | 3,450 | $58.15 | $200,617.50 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,711 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.